Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT06266455 · ClinicalTrials.gov registry record · NA

Individualized Nutrition to Optimize Preterm Infant Growth and Neurodevelopment

A NA study of Very Low Birth Weight Infant and Very Preterm Maturity of Infant, sponsored by Children's National Research Institute.

Recruiting
Registry status
NA
Development phase
150
Enrollment target
1
Study location

NCT06266455 is a NA study of Very Low Birth Weight Infant and Very Preterm Maturity of Infant that is actively recruiting participants, run by Children's National Research Institute. The registered enrollment target is 150 participants, above the 56-participant average among 3 other Very Low Birth Weight Infant trials with a reported enrollment target (168% higher). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT06266455, a NA study of Very Low Birth Weight Infant and Very Preterm Maturity of Infant, is actively recruiting participants, sponsored by Children's National Research Institute.

RECRUITING
Registry status
NA
Development phase
150 participants
Enrollment target
1
Study location

Study Summary

Human milk has several well-established benefits but does not adequately meet the increased nutritional demands of the growing preterm infant, necessitating additional nutrient supplementation in a process known as fortification. In U.S. neonatal intensive care units (NICUs), human milk is primarily supplemented using standardized fortification, in which a multicomponent fortifier is added to human milk to achieve assumed nutrient content based on standard milk reference values. However, this method does not account for the significant variability in human milk composition or in preterm infant metabolism, and up to half of all very premature infants experience poor growth and malnutrition using current nutritional practices. Poor postnatal growth has adverse implications for the developing preterm brain and long-term neurodevelopment. Recent advances allow for individualized methods of human milk fortification, including adjustable and targeted fortification. Adjustable fortification uses laboratory markers of protein metabolism (BUN level) to estimate an infant's protein requirements. In targeted fortification, a milk sample is analyzed to determine its specific macronutrient and energy content, with additional macronutrient supplementation provided as needed to achieve goal values. Emerging data suggest that both methods are safe and effective for improving growth, however information on their comparable efficacy and neurodevelopmental implications are lacking, particularly using advanced quantitative brain MRI (qMRI) techniques. Through this prospective, randomized-controlled trial, the investigators will compare the impact of individualized human milk fortification on somatic growth and neurodevelopment in preterm infants. Infants will be randomized to receive one of three nutritional interventions: standardized (control group), adjustable, or targeted human milk fortification. Infants will undergo their assigned nutritional intervention until term-equivalent

Interventions

  • DIETARY_SUPPLEMENT Standardized Fortification
  • DIETARY_SUPPLEMENT Adjustable Fortification

Study Locations (1)

District of Columbia

  • Children's National Hospital - Washington D.C.

Trial Details

FieldValue
Enrollment Target 150 participants
Start Date 2024-02-08
Est. Completion 2034-01
Phase NA

What the Registry Record Tells You About NCT06266455

The ClinicalTrials.gov registry entry for NCT06266455 describes a study currently listed as recruiting, categorized as NA. The registered enrollment target is 150 participants, a figure that helps gauge the scale of data the investigators plan to collect, above the 56-participant average among 3 other Very Low Birth Weight Infant trials with a reported enrollment target (168% higher). The listed sponsor is Children's National Research Institute, which has 92 total studies on file at ClinicalTrials.gov.

The record links to 2 conditions, with Very Low Birth Weight Infant appearing as the primary indexed condition, and to 2 interventions - of which Standardized Fortification is the first listed.

NCT06266455 reports 1 study location spanning 1 distinct geographic area - top geographies include District of Columbia.

Frequently Asked Questions

What is clinical trial NCT06266455 about?

NCT06266455 is a clinical study titled "Individualized Nutrition to Optimize Preterm Infant Growth and Neurodevelopment". Human milk has several well-established benefits but does not adequately meet the increased nutritional demands of the growing preterm infant, necessitating additional nutrient supplementation in a process known as fortification. In U.S. neonatal intensive care units (NICUs), human milk is primarily...

What is the current status of trial NCT06266455?

This trial is currently recruiting. It is a NA study. The enrollment target is 150 participants. The study started on 2024-02-08. Estimated completion is 2034-01.

What conditions does trial NCT06266455 study?

This clinical trial studies the following conditions: Very Low Birth Weight Infant, Very Preterm Maturity of Infant.

What interventions are being tested in trial NCT06266455?

The interventions under investigation include: Standardized Fortification (DIETARY_SUPPLEMENT), Adjustable Fortification (DIETARY_SUPPLEMENT).

Who is sponsoring clinical trial NCT06266455?

This trial is sponsored by Children's National Research Institute, which has 92 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT06266455 being conducted?

This trial has 1 study location across District of Columbia. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Very Low Birth Weight Infant

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.